文献速递其他结缔组织病

Slit2/Robo4轴可能参与系统性硬化症内皮细胞功能障碍与血管生成紊乱

Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis.
PubMed 文献 · Ann Rheum Dis · 2018-07-18

研究检测了系统性硬化症(SSc)及极早期诊断SSc(VEDOSS)患者循环Slit2水平,并分析Slit2/Robo1/Robo4在SSc皮肤和真皮微血管内皮细胞(MVEC)中的表达及对血管生成的影响。结果发现SSc和VEDOSS循环Slit2显著升高,SSc皮肤和MVEC中Slit2/Robo4上调,Slit2/Robo4轴通过抑制Src激酶磷酸化干扰血管生成,可能从极早期参与外周微血管病变。

要点

  • SSc和VEDOSS患者循环Slit2较健康对照显著升高。
  • VEDOSS伴甲襞 videocapillaroscopy(NVC)异常者血清Slit2升高,NVC正常者与对照相似。
  • Slit2/Robo4轴通过抑制Src激酶磷酸化干扰MVEC血管生成,Slit2中和或ROBO4基因沉默可改善SSc-MVEC血管生成。

核心结论

  • 在SSc中,循环Slit2水平升高及Slit2/Robo4抗血管生成轴的激活可能从疾病极早期即参与外周微血管病变。

研究设计与样本

  • 研究检测SSc患者与健康对照的循环Slit2水平,并比较SSc与健康皮肤活检及分离的真皮微血管内皮细胞(MVEC)中Slit2、Robo1和Robo4的表达。
  • 通过细胞活力、伤口愈合和毛细管样管腔形成实验研究Slit2/Robo4在MVEC血管生成中的功能。

主要发现

  • 循环Slit2在SSc或极早期诊断SSc(VEDOSS)患者中均较对照显著升高。
  • VEDOSS伴甲襞 videocapillaroscopy(NVC)异常者血清Slit2水平升高,而NVC正常的VEDOSS与对照相似。
  • 在SSc中,临床受累皮肤和分离的MVEC中Slit2与Robo4表达较对照上调。
  • 健康MVEC经重组人Slit2或SSc血清刺激后血管生成能力显著降低,SSc血清预孵育抗Slit2阻断抗体后这些抑制作用显著减弱。
  • SSc-MVEC体外血管生成严重受损,Slit2中和或ROBO4基因沉默可显著改善;Slit2/Robo4轴通过抑制Src激酶磷酸化干扰血管生成。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In systemic sclerosis (SSc), early microvascular injury is followed by impaired angiogenesis and peripheral capillary loss. Here, we investigated the possible contribution of the neurovascular guidance molecule Slit2 and its Roundabout (Robo) receptors to SSc-related endothelial cell dysfunction. METHODS: Circulating Slit2 levels were measured in patients with SSc and healthy controls. Slit2, Robo1 and Robo4 expression was investigated in SSc and healthy skin biopsies and explanted dermal microvascular endothelial cells (MVECs). Slit2/Robo4 function in MVEC angiogenesis was studied by cell viability, wound healing and capillary-like tube formation assays. RESULTS: Circulating Slit2 was significantly increased in either SSc or patients with a very early diagnosis of SSc (VEDOSS) compared with controls. Interestingly, serum Slit2 levels were raised in patients with VEDOSS with nailfold videocapillaroscopy (NVC) abnormalities, while they were similar in VEDOSS with normal NVC and controls. In SSc, Slit2 and Robo4 expression was upregulated in clinically affected skin and explanted MVECs in respect to controls. The angiogenic performance of healthy MVECs was significantly reduced after challenge with recombinant human Slit2 or SSc sera. These inhibitory effects were significantly attenuated when SSc sera were preincubated with an anti-Slit2 blocking antibody. In vitro angiogenesis was severely compromised in SSc-MVECs and could be significantly ameliorated by Slit2 neutralisation or ROBO4 gene silencing. Slit2/Robo4 axis interfered with angiogenesis through the inhibition of Src kinase phosphorylation. CONCLUSIONS: In SSc, increased circulating levels of Slit2 and activation of the Slit2/Robo4 antiangiogenic axis may contribute to peripheral microangiopathy since the very early phase of the disease.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Romano E, Manetti M, Rosa I, et al. Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis. Ann Rheum Dis. 2018. PMID: 30021803. doi:10.1136/annrheumdis-2018-213239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。